Ilaris Prices, Coupons, Copay Cards & Patient Assistance
Ilaris (canakinumab) is a member of the interleukin inhibitors drug class and is commonly used for Cryopyrin-Associated Periodic Syndromes, Familial Cold Autoinflammatory Syndrome, Familial Mediterranean Fever, and others.
The cost for Ilaris (150 mg/mL) subcutaneous solution is around $21,121 for a supply of 1 milliliter(s), depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Ilaris prices
Subcutaneous Solution
150 mg/mL
Ilaris subcutaneous solution
from $21,120.61
for 1 milliliter(s)
Quantity | Per unit | Price |
---|---|---|
1 milliliter | $21,120.61 | $21,120.61 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Ilaris Coupons, Copay Cards and Rebates
Ilaris offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Ilaris Co-pay Assistance Program
Eligible commercially insured patients may pay no more than $30 per prescription per calendar year
- Applies to:
- Ilaris
- Number of uses:
- per prescription per calendar year
Form more information phone: 866-972-8315 or Visit website
Patient Assistance & Copay Programs for Ilaris
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Novartis Patient Assistance Foundation, Inc. (NPAF)
Eligibility requirements:- Contact program for details.
- Based on FPL
- Not specified
- Must be residing in the US or US territory
- Fabhalta: To start the application process apply to support.Fabhalta.com or (833) 993-2242. Kesimpta: To start the application process apply to Alongsideā¢ Kesimpta at www.Kesimpta.com or (855) 537-4678. Kisqali: To start the application process apply to support.Kisqali.com or (866) 433-8000. Leqvio: To start the application process apply to Leqvio Service Center at www.Leqvio.com or (833) 537-8462. Lutathera: To start the application process call (844) 638-7222. Pluvicto: To start the application process call (844) 638-7222. Scemblix: To start the application process apply to support.Scemblix.com or (866) 433-8000. All medication will be shipped directly to the patient, unless otherwise noted. Please contact the program for a complete product listing. www.pap.novartis.com
- Ilaris (canakinumab) Injection; Subcutaneous
More information please phone: 800-277-2254 Visit Website
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Ilaris (canakinumab) Injection; Subcutaneous
More information please phone: 866-316-7263 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
More about Ilaris (canakinumab)
- Check interactions
- Compare alternatives
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español